Table of Contents Author Guidelines Submit a Manuscript
Journal of Addiction
Volume 2017, Article ID 6716929, 9 pages
https://doi.org/10.1155/2017/6716929
Research Article

High Rates of Tramadol Use among Treatment-Seeking Adolescents in Malmö, Sweden: A Study of Hair Analysis of Nonmedical Prescription Opioid Use

1Psychiatry, Department of Clinical Sciences, Lund, Faculty of Medicine, Lund University, 221 00 Lund, Sweden
2Department of Forensic Genetics and Forensic Toxicology, Swedish National Board of Forensic Medicine, Linköping, Sweden
3Division of Drug Research, Linköping University, 581 85 Linköping, Sweden

Correspondence should be addressed to Martin O. Olsson; es.ul.dem@nosslo.o_nitram

Received 21 September 2017; Accepted 6 December 2017; Published 24 December 2017

Academic Editor: Leandro F. Vendruscolo

Copyright © 2017 Martin O. Olsson et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. C. Dart, H. L. Surratt, T. J. Cicero et al., “Trends in opioid analgesic abuse and mortality in the United States,” The New England Journal of Medicine, vol. 372, no. 3, pp. 241–248, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. I. Giraudon, K. Lowitz, P. I. Dargan, D. M. Wood, and R. C. Dart, “Prescription opioid abuse in the UK,” British Journal of Clinical Pharmacology, vol. 76, no. 5, pp. 823-824, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. S. P. Novak, A. Håkansson, J. Martinez-Raga, J. Reimer, K. Krotki, and S. Varughese, “Nonmedical use of prescription drugs in the European Union,” BMC Psychiatry, vol. 16, no. 1, article no. 274, 2016. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Zozel, B. Buchel Bartenson, E. Bailey, S. Lowenstein, and R. C. Dart, “Characterization of adolescent prescription drug abuse and misuse using the Researched Abuse Diversion and Addiction-Related Surveillance (RADARS®) System,” Journal of the American Academy of Child & Adolescent Psychiatry, vol. 52, no. 2, pp. 196–204, 2013. View at Google Scholar
  5. M. Tjäderborn, A. K. Jönsson, S. Hägg, and J. Ahlner, “Fatal unintentional intoxications with tramadol during 1995-2005,” Forensic Science International, vol. 173, no. 2-3, pp. 107–111, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Tjäderborn, A. K. Jönsson, J. Ahlner, and S. Hägg, “Tramadol dependence: A survey of spontaneously reported cases in Sweden,” Pharmacoepidemiology and Drug Safety, vol. 18, no. 12, pp. 1192–1198, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Babalonis, M. R. Lofwall, P. A. Nuzzo, A. J. Siegel, and S. L. Walsh, “Abuse liability and reinforcing efficacy of oral tramadol in humans,” Drug and Alcohol Dependence, vol. 129, no. 1-2, pp. 116–124, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Randall and J. Crane, “Tramadol deaths in Northern Ireland: A review of cases from 1996 to 2012,” Journal of Forensic and Legal Medicine, vol. 23, pp. 32–36, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Shadnia, K. Soltaninejad, K. Heydari, G. Sasanian, and M. Abdollahi, “Tramadol intoxication: A review of 114 cases,” Human & Experimental Toxicology, vol. 27, no. 3, pp. 201–205, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. J. S. Gardner, D. Blough, C. R. Drinkard et al., “Tramadol and seizures: A surveillance study in a managed care population,” Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, vol. 20, no. 12, pp. 1423–1431, 2000. View at Publisher · View at Google Scholar · View at Scopus
  11. V. Jovanović-Čupić, Ž. Martinović, and N. Nešić, “Seizures associated with intoxication and abuse of tramadol,” Clinical Toxicology, vol. 44, no. 2, pp. 143–146, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. M. G. Ripple, J. P. Pestaner, B. S. Levine, and J. E. Smialek, “Lethal combination of tramadol and multiple drugs affecting serotonin,” The American Journal of Forensic Medicine and Pathology, vol. 21, no. 4, pp. 370–374, 2000. View at Publisher · View at Google Scholar · View at Scopus
  13. M. M. Bassiony, G. M. Salah El-Deen, U. Yousef et al., “Adolescent tramadol use and abuse in Egypt,” American Journal of Drug and Alcohol Abuse, vol. 41, no. 3, pp. 206–211, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Nazarzadeh, Z. Bidel, and K. V. Carson, “The association between tramadol hydrochloride misuse and other substances use in an adolescent population: Phase I of a prospective survey,” Addictive Behaviors, vol. 39, no. 1, pp. 333–337, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. D. D. Maiga, H. Seyni, A. O. Moussa, and A. Sidikou, “Tramadol misuse by adolescents and young adults living on the streets,” The Pan African Medical Journal, vol. 13, no. 55, 2012. View at Google Scholar · View at Scopus
  16. H. Alblooshi, G. K. Hulse, A. El Kashef et al., “The pattern of substance use disorder in the United Arab Emirates in 2015: Results of a National Rehabilitation Centre cohort study,” Substance Abuse Treatment, Prevention, and Policy, vol. 11, no. 1, article no. 19, 2016. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Berge, A. Håkansson, and M. Berglund, “Alcohol and drug use in groups of cannabis users: Results from a survey on drug use in the Swedish general population,” American Journal on Addictions, vol. 23, no. 3, pp. 272–279, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. A.-K. Danielsson, E. Agardh, T. Hemmingsson, P. Allebeck, and D. Falkstedt, “Cannabis use in adolescence and risk of future disability pension: A 39-year longitudinal cohort study,” Drug and Alcohol Dependence, vol. 143, no. 1, pp. 239–243, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Hodgins, P. Larm, Y. Molero-Samuleson, A. Tengström, and A. Larsson, “Multiple adverse outcomes over 30 years following adolescent substance misuse treatment,” Acta Psychiatrica Scandinavica, vol. 119, no. 6, pp. 484–493, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. A. R. Winstock, R. Borschmann, and J. Bell, “The non-medical use of tramadol in the UK: Findings from a large community sample,” International Journal of Clinical Practice, vol. 68, no. 9, pp. 1147–1151, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. T. Richert and B. Johnson, “Illicit use of methadone and buprenorphine among adolescents and young adults in Sweden,” Harm Reduction Journal, vol. 10, no. 1, article no. 27, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. CAN, Läkemedel i missbruksmiljöer (Pharmaceutical drugs on the drug scene), CAN, Stockholm, Sweden, 2016.
  23. M. Tjäderborn, A. K. Jönsson, T. Z. Sandström, J. Ahlner, and S. Hägg, “Non-prescribed use of psychoactive prescription drugs among drug-impaired drivers in Sweden,” Drug and Alcohol Dependence, vol. 161, pp. 77–85, 2016. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Swendsen, M. Burstein, B. Case et al., “Use and abuse of alcohol and illicit drugs in US adolescents: Results of the National Comorbidity Survey-Adolescent Supplement,” Archives of General Psychiatry, vol. 69, no. 4, pp. 390–398, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. T. D. Saha, B. T. Kerridge, R. B. Goldstein et al., “Nonmedical prescription opioid use and DSM-5 nonmedical prescription opioid use disorder in the United States,” Journal of Clinical Psychiatry, vol. 77, no. 6, pp. 772–780, 2016. View at Publisher · View at Google Scholar · View at Scopus
  26. M. M. Bassiony, U. M. Youssif, R. A. Hussein, and M. Saeed, “Psychiatric comorbidity among egyptian patients with opioid use disorders attributed to tramadol,” Journal of Addiction Medicine, vol. 10, no. 4, pp. 262–268, 2016. View at Publisher · View at Google Scholar · View at Scopus
  27. R. Kronstrand and K. Scott, “Drug incorporation into hair,” in Analytical and Practical Aspects of Drug Testing in Hair, P. Kintz, Ed., Taylor & Francis, Boca Raton, Fla, USA, 2007. View at Google Scholar
  28. G. A. A. Cooper, R. Kronstrand, and P. Kintz, “Society of Hair Testing guidelines for drug testing in hair,” Forensic Science International, vol. 218, no. 1-3, pp. 20–24, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. P. Kintz, “2014 consensus for the use of alcohol markers in hair for assessment of both abstinence and chronic excessive alcohol consumption,” Forensic Science International, vol. 249, pp. A1–A2, 2015. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Salomone, L. Tsanaclis, R. Agius, P. Kintz, and M. R. Baumgartner, “European guidelines for workplace drug and alcohol testing in hair,” Drug Testing and Analysis, vol. 8, no. 10, pp. 996–1004, 2016. View at Publisher · View at Google Scholar · View at Scopus
  31. H. Druid, J. J. Strandberg, K. Alkass, I. Nyström, F. C. Kugelberg, and R. Kronstrand, “Evaluation of the role of abstinence in heroin overdose deaths using segmental hair analysis,” Forensic Science International, vol. 168, no. 2-3, pp. 223–226, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. F. Musshoff, K. Lachenmeier, J. Trafkowski, B. Madea, F. Nauck, and U. Stamer, “Determination of opioid analgesics in hair samples using liquid chromatography/tandem mass spectrometry and application to patients under palliative care,” Therapeutic Drug Monitoring, vol. 29, no. 5, pp. 655–661, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. C. Andersson, A. Öjehagen, M. O. Olsson, L. Brådvik, and A. Håkansson, “Interactive voice response with feedback intervention in outpatient treatment of substance use problems in adolescents and young adults: a randomized controlled trial,” International Journal of Behavioral Medicine, vol. 24, no. 5, pp. 789–797, 2017. View at Publisher · View at Google Scholar · View at Scopus
  34. H. Jenner and V. Segraeus, “The Swedish DOC system - An attempt to combine documentation and self-evaluation,” European Addiction Research, vol. 11, no. 4, pp. 186–192, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. D. V. Sheehan, Y. Lecrubier, K. H. Sheehan et al., “The mini-international neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10,” Journal of Clinical Psychiatry, vol. 59, no. 20, pp. 22–33, 1998. View at Google Scholar · View at Scopus
  36. T. D. Armstrong and E. J. Costello, “Community studies on adolescent substance use, abuse, or dependence and psychiatric comorbidity,” Journal of Consulting and Clinical Psychology, vol. 70, no. 6, pp. 1224–1239, 2002. View at Publisher · View at Google Scholar · View at Scopus
  37. J. J. Wilson and F. R. Levin, “Attention-deficit/hyperactivity disorder and early-onset substance use disorders,” Journal of Child and Adolescent Psychopharmacology, vol. 15, no. 5, pp. 751–763, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders, American Psychiatric Association, Washington, DC, USA, 4th edition, 2000. View at Publisher · View at Google Scholar
  39. R. Kronstrand, I. Nyström, J. Strandberg, and H. Druid, “Screening for drugs of abuse in hair with ion spray LC-MS-MS,” Forensic Science International, vol. 145, no. 2-3, pp. 183–190, 2004. View at Publisher · View at Google Scholar · View at Scopus
  40. R. Kronstrand, M. Forsman, and M. Roman, “A screening method for 30 drugs in hair using ultrahigh-performance liquid chromatography time-of-flight mass spectrometry,” Therapeutic Drug Monitoring, vol. 35, no. 3, pp. 288–295, 2013. View at Publisher · View at Google Scholar · View at Scopus
  41. G. Hajak, W. E. Müller, H. U. Wittchen, D. Pittrow, and W. Kirch, “Abuse and dependence potential for the non-benzodiazepine hypnotics zolpidem and zopiclone: a review of case reports and epidemiological data,” Addiction, vol. 98, no. 10, pp. 1371–1378, 2003. View at Publisher · View at Google Scholar · View at Scopus
  42. B. J. Shapiro, K. L. Lynch, T. Toochinda, A. Lutnick, H. Y. Cheng, and A. H. Kral, “Promethazine misuse among methadone maintenance patients and community-based injection drug users,” Journal of Addiction Medicine, vol. 7, no. 2, pp. 96–101, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. D. Dahlman, T. Abrahamsson, A. H. Kral, and A. Hakansson, “Nonmedical use of antihistaminergic anxiolytics and other prescription drugs among persons with opioid dependence,” Journal of Addiction Medicine, vol. 2016, Article ID 9298571, 11 pages, 2016. View at Publisher · View at Google Scholar
  44. D. Debruyne and R. Le Boisselier, “Emerging drugs of abuse: current perspectives on synthetic cannabinoids,” Substance Abuse and Rehabilitation, vol. 6, pp. 113–129, 2015. View at Publisher · View at Google Scholar
  45. M. Mahic, O. M. Fredheim, P. C. Borchgrevink, and S. Skurtveit, “Use of prescribed opioids by children and adolescents: Differences between Denmark, Norway and Sweden,” European Journal of Pain, vol. 19, no. 8, pp. 1095–1100, 2015. View at Publisher · View at Google Scholar · View at Scopus
  46. E. Bäckryd, M. Heilig, and M. Hoffman, “Dynamiken i förskrivningen av opioider i Sverige 2000–2015—Markanta omfördelningar inom opioidgruppen, men ingen 'epidemi',” Läkartidningen, vol. 114, 2017. View at Google Scholar
  47. K. Käll and A. Nilsonne, “Preference for sex on amphetamine: a marker for HIV risk behaviour among male intravenous amphetamine users in Stockholm,” AIDS Care, vol. 7, no. 2, pp. 171–188, 1995. View at Publisher · View at Google Scholar · View at Scopus
  48. L. Kraus, R. Augustin, M. Frischer, P. Kümmler, A. Uhl, and L. Wiessing, “Estimating prevalence of problem drug use at national level in countries of the European Union and Norway,” Addiction, vol. 98, no. 4, pp. 471–485, 2003. View at Publisher · View at Google Scholar · View at Scopus
  49. C. Haasen, M. Prinzleve, H. Zurhold et al., “Cocaine use in Europe - A multi-centre study: Methodology and prevalence estimates,” European Addiction Research, vol. 10, no. 4, pp. 139–146, 2004. View at Publisher · View at Google Scholar · View at Scopus
  50. CAN, Drogutvecklingen i Sverige, (The development of the drug situation), CAN, Stockholm, Sweden, 2014.
  51. CAN, Narkotikaprisutvecklingen i Sverige, 1988–2015 (The development of the street price of drugs, 1988–2015), CAN, Stockholm, Sweden, 2016.
  52. J. Mounteney, P. Griffiths, R. Sedefov, A. Noor, J. Vicente, and R. Simon, “The drug situation in Europe: an overview of data available on illicit drugs and new psychoactive substances from European monitoring in 2015,” Addiction, vol. 111, no. 1, pp. 34–48, 2016. View at Publisher · View at Google Scholar · View at Scopus
  53. Swedish Television, http://www.svt.se/nyheter/lokalt/skane/tramadol-ungdomarnas-nya-favoritdrog.
  54. P. Larm, S. Hodgins, A. Larsson, Y. M. Samuelson, and A. Tengström, “Long-term outcomes of adolescents treated for substance misuse,” Drug and Alcohol Dependence, vol. 96, no. 1-2, pp. 79–89, 2008. View at Publisher · View at Google Scholar · View at Scopus
  55. S. Hodgins, B. R. Oliver, A. Tengström, and A. Larsson, “Adolescents who consulted for substance misuse problems: Outcomes 1 year later,” Nordic Journal of Psychiatry, vol. 64, no. 3, pp. 189–195, 2010. View at Publisher · View at Google Scholar · View at Scopus
  56. J. Barber, “Examining the use of tramadol hydrochloride as an antidepressant,” Experimental and Clinical Psychopharmacology, vol. 19, no. 2, pp. 123–130, 2011. View at Publisher · View at Google Scholar · View at Scopus
  57. M. O. Rojas-Corrales, E. Berrocoso, J. Gibert-Rahola, and J. A. Micó, “Antidepressant-like effect of tramadol and its enantiomers in reserpinized mice: Comparative study with desipramine, fluvoxamine, venlafaxine and opiates,” Journal of Psychopharmacology, vol. 18, no. 3, pp. 404–411, 2004. View at Publisher · View at Google Scholar · View at Scopus
  58. R. R. Reeves and R. S. Burke, “Tramadol: Basic pharmacology and emerging concepts,” Drugs of Today, vol. 44, no. 11, pp. 827–836, 2008. View at Publisher · View at Google Scholar · View at Scopus
  59. R. R. Reeves and S. K. Cox, “Similar effects of tramadol and venlafaxine in major depressive disorder,” Southern Medical Journal, vol. 101, no. 2, pp. 193–195, 2008. View at Publisher · View at Google Scholar · View at Scopus